Inventor · disambiguated record
Leslie Wighton Mcquire
Also filed as: MCQUIRE LESLIE W · MCQUIRE LESLIE WIGHTON
18 granted patents·8 pending applications·337 citations·filing 1998–2015
94Inventor score
Files withNOVARTIS AG14ADAMS CHRISTOPHER MICHAEL2GAMBER GABRIEL G2MCQUIRE LESLIE WIGHTON2ADAMS CHRISTOPHER1
Top patents by PatentIndex Score
26 records- 0194US6291523B1Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 1998·Granted Sep 18, 2001·117 cites·36 claims
- 0293US6310099B1Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2000·Granted Oct 30, 2001·54 cites·19 claims
- 0391US6353017B1Dipeptide nitrilesNOVARTIS AG·Filed 2000·Granted Mar 5, 2002·52 cites·22 claims
- 0490US6174888B12-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-onesNOVARTIS AG·Filed 1998·Granted Jan 16, 2001·48 cites·9 claims
- 0588US8030334B2Organic compoundsNOVARTIS AG·Filed 2009·Granted Oct 4, 2011·9 cites·13 claims
- 0684US6812237B2N-substituted peptidyl nitriles as cysteine cathepsin inhibitorsNOVARTIS AG·Filed 2001·Granted Nov 2, 2004·15 cites·16 claims
- 0784US6727281B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2002·Granted Apr 27, 2004·13 cites·17 claims
- 0881US6451858B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2001·Granted Sep 17, 2002·10 cites·10 claims
- 0976US8362063B2Arylsulfonamide based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2012·Granted Jan 29, 2013·2 cites·6 claims
- 1075US7115662B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2003·Granted Oct 3, 2006·5 cites·18 claims
- 1174US8791141B2Organic compoundsADAMS CHRISTOPHER·Filed 2009·Granted Jul 29, 2014·1 cites·9 claims
- 1271US7202364B2Certain phenylacetic acids and derivativesNOVARTIS AG·Filed 2003·Granted Apr 10, 2007·7 cites·10 claims
- 1364US9822092B2ArylSulfonamide-based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2014·Granted Nov 21, 2017·0 cites·15 claims
- 1461US2014288126A1Organic compoundsADAMS CHRISTOPHER MICHAEL·Filed 2014·Application pending·0 cites
- 1560US8975439B2Arylsulfonamide based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2012·Granted Mar 10, 2015·0 cites·7 claims
- 1660US8222424B2Arylsulfonamide-based matrix metalloprotease inhibitorsEHRHARDT CLAUS·Filed 2009·Granted Jul 17, 2012·0 cites·6 claims
- 1757US2008027060A1Dipeptide nitrilesALTMANN EVA·Filed 2007·Application pending·0 cites
- 1854US9242963B2Organic compoundsADAMS CHRISTOPHER MICHAEL·Filed 2015·Granted Jan 26, 2016·0 cites·11 claims
- 1953US2011112076A1Selective hydroxamic acid based mmp-12 and mmp-13 inhibitorsMCQUIRE LESLIE WIGHTON·Filed 2009·Application pending·0 cites
- 2051US2009306373A14,7-dihydrothieno[2,3-b]pyridine compounds and pharmaceutical compositionsGAMBER GABRIEL G·Filed 2006·Application pending·0 cites
- 2151US2007060569A1Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitorsFUJIMOTO ROGER A·Filed 2006·Application pending·0 cites
- 2251US2011105496A1Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine CompoundsGAMBER GABRIEL G·Filed 2006·Application pending·0 cites
- 2350US2004029814A1Dipeptide nitrilesFiled 2003·Application pending·0 cites
- 2445US8841291B2Selective hydroxamic acid based MMP-12 and MMP-13 inhibitorsMCQUIRE LESLIE WIGHTON·Filed 2013·Granted Sep 23, 2014·0 cites·2 claims
- 2545US2004235896A1Certain azacycloalkyl substituted acetic acid derivativesFiled 2002·Application pending·0 cites
- 2641US6043365APreparation of 2-amino-7-(1-substituted-2-hydroxyethyl)-3, 5-dihydropyrrolo[3,2-d]pyrimidin-4-onesNOVARTIS AG·Filed 1998·Granted Mar 28, 2000·4 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →